Dian Diagnostics Group Co.,Ltd. Stock: price and insider trades · China
迪安诊断
No insider purchase over the last 90 days. The latest, by 刘贞, was filed 22 Jul 2026.
Dian Diagnostics Group Co.,Ltd.: what insiders have been doing
Dian Diagnostics Group Co.,Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). Between 7 November 2025 and 7 November 2026, 1 insider published 1 filing.
Only purchases show up on the open market, 1 purchase in all worth €2,965, filed by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 1 senior executive. The largest single trade was a purchase of €2,965 by 刘贞, published on 22 July 2026.
Compared with its exchange (522 companies, median 2 filings), a count of 1 filing is below the norm. Since 2021, the database holds 1 purchase and 4 sales by insiders of the company.
The last purchase on record was published on 22 July 2026, which is 109 days ago.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- +29.9%Entry CN¥16.51 · Close 06 Nov 2026 CN¥21.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Dian Diagnostics Group Co.,Ltd. Hold (neutral), based on 6 analysts. Average price target: CN¥19.99.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,300 shares@ CN¥135.8157100.0% of flowA股XSHESZSE:273000000870816600Canonical exit: 20 Oct 2026 (T+90)
- 300,000 shares7.8% of flowA股XSHESZSE:173000005637394140
- 3,000,000 shares73.5% of flowA股XSHESZSE:173000005637160000
- 232,800 shares5.9% of flowA股XSHESZSE:173000005637368160
- 516,600 shares12.8% of flowA股XSHESZSE:173000005637265630
5 of 5 declarations
About Dian Diagnostics Group Co.,Ltd.
迪安诊断 is a company specializing in medical diagnostic services in China. It offers laboratory tests and health solutions to enhance the diagnosis and treatment of diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
